On September 20, the FDA approved isatuximab plus bortezomib, lenalidomide, and dexamethasone in the first line for patients who have multiple myeloma and are ineligible for transplant.
Sanofi should hear from the FDA in September about its application for Sarclisa as a first-line therapy for multiple myeloma after the US regulator gave it a priority review. The French pharma ...
Choice Hotels International ... Going forward, CHH believes that it is well positioned to deliver bottom-line growth as well as maintain its shareholder value on the back of the aforementioned ...
Commissions do not affect our editors' opinions or evaluations. A business line of credit is a handy way to access financing as needed rather than receiving a lump-sum payment such as with a small ...
Fidelity offers multiple account types ... Fidelity can be a great choice for most investment needs, but it's especially strong for investors with a long-term retirement focus.
While that may not cause you to overlook Tennessee's 2-11 ATS record, it could sway you towards other home squads getting points in the Week 15 NFL betting lines. Which teams should factor into ...